RXO

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 1.67 B1.43 B1.42 B1.42 B1.47 B1.43 B 5.73 B Gross profit 310 M280 M301 M284 M266 M254 M 1.1 B Operating expenses 279 M224 M231 M229 M297 M208 M 965 M Selling/general/admin expenses 218 M210 M214 M208 M200 M197 M 819 M Research & development —————— — Operating income -24 M-30 M0-7 M-42 M-28 M -77 M Non-Operating Income, Total -2 M0-2 M1 M1 M-1 M -1 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000000 0 Unusual income/expense -2 M0-2 M1 M1 M-1 M -1 M Pretax income -33 M-39 M-10 M-15 M-51 M-49 M -125 M Equity in earnings —————— — Taxes -8 M-8 M-1 M-1 M-5 M-13 M -20 M Non-controlling/minority interest —————— — After tax other income/expense -4 M-2 M-4 M-1 M-4 M-2 M -11 M Net income before discontinued operations -25 M-31 M-9 M-14 M-46 M-36 M -105 M Discontinued operations —————— — Net income -25 M-31 M-9 M-14 M-46 M-36 M -105 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -25 M-31 M-9 M-14 M-46 M-36 M -105 M Basic earnings per share (Basic EPS) -0.17-0.18-0.05-0.08-0.28-0.21 -0.62 Diluted earnings per share (Diluted EPS) -0.17-0.18-0.05-0.08-0.28-0.21 -0.62 Average basic shares outstanding 133.41 M168.02 M168.53 M168.58 M168.46 M169.1 M — Diluted shares outstanding 133.41 M168.02 M168.53 M168.58 M168.46 M169.1 M — EBITDA 64 M88 M100 M81 M-3 M72 M 250 M EBIT 31 M56 M70 M55 M-31 M46 M 140 M Cost of revenue 1.36 B1.15 B1.12 B1.14 B1.2 B1.17 B 4.63 B Other cost of goods sold 1.36 B1.15 B1.12 B1.14 B1.2 B1.17 B 4.63 B Depreciation & amortization (cash flow) 33 M32 M30 M26 M28 M26 M 110 M